BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
376.86
+7.71 (2.09%)
At close: Aug 19, 2026, 4:00 PM EDT
376.66
-0.20 (-0.05%)
Pre-market: Aug 20, 2026, 8:28 AM EDT
BeOne Medicines AG Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 1,705 | 1,513 | 1,498 | 1,412 | 1,315 | 1,117 | 1,128 | 1,002 | 929.17 | 751.65 | 643.04 | 721.49 | 595.26 | 447.8 | 380.1 | 387.63 | 341.57 | 306.63 | 213.98 | 206.44 |
Revenue Growth | 29.63% | 35.46% | 32.84% | 41.00% | 41.56% | 48.64% | 75.39% | 38.82% | 56.09% | 67.85% | 69.18% | 86.13% | 74.27% | 46.04% | 77.63% | 87.77% | 127.73% | -49.39% | 113.77% | 126.66% |
Gross Profit Gross Profit Growth | 1,531 | 1,346 | 1,356 | 1,216 | 1,151 | 952.28 | 967.26 | 831.14 | 791.03 | 626.72 | 531.11 | 638.83 | 499.27 | 366.01 | 1,501 | -115.28 | -107.81 | -148.53 | -265.05 | -192.91 |
Operating Income Operating Income Growth | 325.05 | 249.9 | 185.04 | 163.11 | 87.89 | 11.1 | -79.43 | -120.27 | -107.16 | -261.35 | -381.45 | -113.81 | -318.72 | -371.26 | -469.43 | -438.36 | -439.4 | -443.29 | -573.3 | -462.33 |
Net Income Net Income Growth | 237.01 | 227.36 | 66.5 | 124.84 | 94.32 | 1.27 | -151.88 | -121.35 | -120.41 | -251.15 | -334.79 | 198.07 | -381.14 | -348.43 | -445.34 | -557.56 | -565.73 | -435.2 | -590.68 | -438.11 |
Earnings Per Share EPS Growth | 2.08 | 1.95 | 0.52 | 1.04 | 0.78 | 0.01 | -1.44 | -1.17 | -1.17 | -2.47 | -3.22 | 1.88 | -3.64 | -3.34 | -4.35 | -5.39 | -5.50 | -4.25 | -6.28 | -4.72 |
EPS Growth | 166.67% | 16970.81% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
BRUKINSA BRUKINSA Growth | 1,248 | 1,095 | 1,146 | 1,041 | 949.84 | 791.66 | 828.03 | 690.28 | 637.4 | 488.52 | 413.04 | 357.7 | 308.28 | 211.38 | 176.08 | 155.5 | 128.75 | 104.33 | 87.64 | 65.83 |
TEVIMBRA TEVIMBRA Growth | 228.52 | 206.24 | 181.99 | 190.62 | 193.52 | 171.16 | 153.8 | 163.35 | 158.41 | 145.28 | 127.95 | 144.35 | 149.46 | 114.85 | 102.16 | 128.21 | 104.88 | 87.64 | 54.38 | 76.98 |
XGEVA XGEVA Growth | 104.5 | 89.92 | 70 | 84.24 | 81.32 | 70.42 | 62.52 | 63.45 | 55.05 | 43.38 | 24.21 | 24.46 | 23.97 | 20.2 | 16.24 | 18.15 | 15.51 | 13.5 | 12.47 | 15.7 |
BLINCYTO BLINCYTO Growth | 36.54 | 34.04 | 24.26 | 30.48 | 25.59 | 23.91 | 20.62 | 20.22 | 19.13 | 14.37 | 13.95 | 14.87 | 14.58 | 10.95 | 8.5 | 6.21 | 9.53 | 11.87 | 7.48 | 5.04 |
KYPROLIS KYPROLIS Growth | 15.15 | 16.97 | 17.46 | 18.37 | 19.42 | 19.73 | 18.15 | 17.97 | 15.94 | 14.11 | 12.7 | 11.1 | 11.05 | 4.94 | 2.47 | 2.82 | 4.09 | 4.31 | - | - |
POBEVCY POBEVCY Growth | 9.63 | 12.13 | 11.91 | 10.5 | 11.24 | 13.75 | 13.11 | 12.19 | 11.57 | 16.63 | 14.65 | 14.13 | 13.44 | 14.33 | 8.45 | 9.87 | 12.98 | 6.82 | 1.35 | - |
Total Other Product Total Other Product Growth | 37.82 | 33.19 | 24.53 | 20.11 | 21.15 | 17.9 | 21.8 | 25.99 | 23.64 | 24.64 | 24.02 | 28.69 | 32.97 | 33.65 | 25.12 | 24.17 | 23.32 | 25.05 | 26.73 | 21.58 |
Collaboration Collaboration Growth | 25.28 | 26.11 | 21.73 | 17.27 | 13.22 | 8.75 | 9.79 | 8.15 | 8.02 | 4.73 | 3.88 | 186.02 | 41.52 | 37.51 | 41.07 | 38.12 | 37.06 | 45.05 | 17.19 | 13.98 |
Revenue (Total) Revenue (Total) Growth | 1,705 | 1,513 | 1,498 | 1,412 | 1,315 | 1,117 | 1,128 | 1,002 | 929.17 | 751.65 | 713.44 | 781.31 | 595.26 | 447.8 | 380.1 | 387.63 | 341.57 | 306.63 | 213.98 | 206.44 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 5,098 | 4,792 | 4,548 | 4,037 | 2,756 | 2,516 | 2,627 | 2,714 | 2,593 | 2,793 | 3,172 | 3,174 | 3,516 | 3,868 | 4,535 | 5,080 | 5,704 | 6,245 | 6,621 | 3,917 |
Total Debt Total Debt Growth | 2,050 | 2,053 | 2,000 | 1,905 | 1,026 | 996.83 | 1,080 | 1,053 | 1,090 | 1,063 | 930.19 | 579.77 | 677.81 | 545.19 | 596.68 | 710.58 | 632.65 | 671.88 | 694.64 | 699.54 |
Net Cash (Debt) Net Cash Growth | 3,049 | 2,738 | 2,548 | 2,132 | 1,730 | 1,520 | 1,548 | 1,662 | 1,503 | 1,730 | 2,242 | 2,595 | 2,838 | 3,322 | 3,938 | 4,369 | 5,071 | 5,573 | 5,926 | 3,217 |
Net Cash Growth | 76.18% | 80.20% | 64.63% | 28.31% | 15.15% | -12.18% | -30.96% | -35.96% | -47.06% | -47.92% | -43.08% | -40.62% | -44.03% | -40.39% | -33.54% | 35.81% | 37.00% | 33.53% | 44.94% | -28.10% |
Net Cash Per Share Net Cash Per Share Growth | 26.33 | 23.65 | 22.08 | 18.62 | 15.37 | 13.67 | 14.56 | 15.69 | 14.35 | 16.59 | 21.54 | 24.66 | 27.13 | 31.89 | 37.95 | 42.22 | 49.33 | 54.39 | 62.36 | 34.68 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 462.82 | 201.34 | 417.35 | 402.55 | 263.6 | 44.08 | 75.16 | 188.37 | -95.59 | -308.57 | -395.69 | 117.38 | -293.89 | -563.78 | -318.19 | -561.91 | -379.96 | -236.56 | -507.84 | -495.71 |
Capital Expenditures CapEx Growth | -27.48 | -40.79 | -37.52 | -48.08 | -43.83 | -56.41 | -92.48 | -133.66 | -109.95 | -156.58 | -125.13 | -177.39 | -121.47 | -125.59 | -121.36 | -108.66 | -50.29 | -45.13 | -114.98 | -67.04 |
Free Cash Flow Free Cash Flow Growth | 435.34 | 160.55 | 379.83 | 354.47 | 219.77 | -12.33 | -17.32 | 54.71 | -205.54 | -465.15 | -520.82 | -60.02 | -415.36 | -689.36 | -439.55 | -670.56 | -430.25 | -281.69 | -622.82 | -562.76 |
Free Cash Flow Growth | 98.09% | - | - | 547.86% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | 89.76% | 88.95% | 90.49% | 86.09% | 87.48% | 85.23% | 85.76% | 82.98% | 85.13% | 83.38% | 82.59% | 88.54% | 83.87% | 81.73% | 394.92% | -29.74% | -31.56% | -48.44% | -123.87% | -93.45% |
Operating Margin | 19.06% | 16.51% | 12.35% | 11.55% | 6.68% | 0.99% | -7.04% | -12.01% | -11.53% | -34.77% | -59.32% | -15.77% | -53.54% | -82.91% | -123.50% | -113.09% | -128.64% | -144.57% | -267.92% | -223.95% |
Pretax Margin | 18.33% | 17.13% | 9.96% | 10.42% | 7.57% | 1.87% | -7.57% | -9.81% | -11.40% | -32.39% | -49.84% | 29.56% | -61.73% | -75.24% | -113.38% | -142.21% | -163.24% | -137.38% | -274.23% | -209.78% |
Profit Margin | 13.90% | 15.02% | 4.44% | 8.84% | 7.17% | 0.11% | -13.47% | -12.12% | -12.96% | -33.41% | -52.06% | 27.45% | -64.03% | -77.81% | -117.16% | -143.84% | -165.62% | -141.93% | -276.05% | -212.22% |
FCF Margin | 25.53% | 10.61% | 25.35% | 25.10% | 16.71% | -1.10% | -1.54% | 5.46% | -22.12% | -61.88% | -80.99% | -8.32% | -69.78% | -153.94% | -115.64% | -172.99% | -125.96% | -91.87% | -291.06% | -272.60% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | 48.32 | 64.25 | 117.17 | 547.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Forward PE | 40.13 | 54.01 | 66.95 | 80.95 | 106.02 | 188.25 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 | 76.37 |
P/FCF Ratio | 23.82 | 29.57 | 35.70 | 68.87 | 108.62 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
PS Ratio | 5.17 | 5.74 | 6.29 | 7.54 | 5.83 | 7.01 | 5.16 | 7.18 | 4.95 | 6.02 | 7.83 | 8.88 | 10.39 | 14.46 | 16.13 | 11.18 | 15.66 | 22.13 | 23.67 | 31.89 |